Insider Stock Trading History of Tobias Jeffrey K


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Tobias Jeffrey K since year 2005. The trader's CIK number is 1394522. At the time of this reporting, Tobias Jeffrey K is the EVP, R&D & CMO of Jazz Pharmaceuticals Inc . (stock ticker symbol JAZZ). See this page for all insider trading activities at Jazz Pharmaceuticals Inc .

Note that in the past Tobias Jeffrey K also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Tobias Jeffrey K since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-02-10 JAZZ Jazz Pharmaceuticals Inc Option Ex 5,000 46.83 234,150
2015-02-10 JAZZ Jazz Pharmaceuticals Inc Sale 5,000 166.91 834,545
2014-11-24 JAZZ Jazz Pharmaceuticals Inc Sale 4,598 170.12 782,230
2014-11-14 JAZZ Jazz Pharmaceuticals Inc Sale 1,000 173.32 173,320
2014-10-10 JAZZ Jazz Pharmaceuticals Inc Sale 1,000 154.04 154,040
2014-09-12 JAZZ Jazz Pharmaceuticals Inc Sale 1,000 171.22 171,220
2014-08-11 JAZZ Jazz Pharmaceuticals Inc Option Ex 4,933 52.98 261,350
2014-08-11 JAZZ Jazz Pharmaceuticals Inc Sale 4,933 135.42 668,026
2014-06-09 JAZZ Jazz Pharmaceuticals Inc Sale 3,000 146.24 438,720
2014-06-09 JAZZ Jazz Pharmaceuticals Inc Option Ex 3,000 52.98 158,940
2014-05-16 JAZZ Jazz Pharmaceuticals Inc Sale 1,000 128.01 128,009
2014-04-14 JAZZ Jazz Pharmaceuticals Inc Option Ex 3,000 52.98 158,940
2014-04-14 JAZZ Jazz Pharmaceuticals Inc Sale 3,000 128.54 385,620
2014-03-10 JAZZ Jazz Pharmaceuticals Inc Option Ex 3,000 52.98 158,940
2014-03-10 JAZZ Jazz Pharmaceuticals Inc Sale 3,000 152.99 458,970
2014-02-27 JAZZ Jazz Pharmaceuticals Inc Sale 3,000 165.46 496,380
2014-02-10 JAZZ Jazz Pharmaceuticals Inc Option Ex 2,560 46.83 119,884
2014-02-10 JAZZ Jazz Pharmaceuticals Inc Sale 2,560 152.83 391,244
2013-12-09 JAZZ Jazz Pharmaceuticals Inc Option Ex 1,325 46.83 62,049
2013-12-09 JAZZ Jazz Pharmaceuticals Inc Sale 1,325 117.80 156,085
2013-11-11 JAZZ Jazz Pharmaceuticals Inc Option Ex 2,373 46.83 111,127
2013-11-11 JAZZ Jazz Pharmaceuticals Inc Sale 2,373 98.50 233,740
2013-10-14 JAZZ Jazz Pharmaceuticals Inc Option Ex 5,000 46.83 234,150
2013-10-14 JAZZ Jazz Pharmaceuticals Inc Sale 5,000 82.92 414,600
2013-09-09 JAZZ Jazz Pharmaceuticals Inc Option Ex 5,000 46.83 234,150
2013-09-09 JAZZ Jazz Pharmaceuticals Inc Sale 5,000 87.11 435,550
2013-08-12 JAZZ Jazz Pharmaceuticals Inc Option Ex 7,500 46.83 351,225
2013-08-12 JAZZ Jazz Pharmaceuticals Inc Sale 7,500 80.77 605,775
2011-05-18 NGSX Neurogesx Inc Sale 1,115 2.82 3,144
2011-05-17 NGSX Neurogesx Inc Sale 1,333 2.73 3,639
2011-05-12 NGSX Neurogesx Inc Sale 600 2.91 1,746
2011-05-13 NGSX Neurogesx Inc Sale 733 2.81 2,059
2011-05-16 NGSX Neurogesx Inc Sale 1,333 2.84 3,785
2009-11-30 NGSX Neurogesx Inc Sale 12,077 8.07 97,497
2009-11-30 NGSX Neurogesx Inc Option Ex 12,077 1.25 15,096
2009-11-25 NGSX Neurogesx Inc Sale 9,303 8.38 77,977
2009-11-27 NGSX Neurogesx Inc Option Ex 620 1.25 775
2009-11-27 NGSX Neurogesx Inc Sale 620 8.27 5,129
2009-11-25 NGSX Neurogesx Inc Option Ex 9,303 1.25 11,628

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tobias Jeffrey K (EVP, R&D & CMO of Jazz Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.